TABLE 5.
SIV infection in wild gorilla and chimpanzee populations from different prospected areas in the CP site, southwest Cameroon
| Collection sitea | No. of gorilla samplesb | No. of SIVgor antibody-positive samples | No. of SIVgor-infected gorillasc | No. of chimpanzee samplesb | No. of SIVcpz antibody-positive samples | No. of SIVcpz-infected chimpanzeesc |
|---|---|---|---|---|---|---|
| CP-GR | 111 | 21 | 8 | 5 | 0 | 0 |
| CP-OV | 83 | 5 | 1 | 15 | 0 | 0 |
| CP-MV | 119 | 3 | 2 | 95 | 9 | 2 |
| CP-ML | 7 | 0 | 0 | 49 | 0 | 0 |
| CP-ON | 116 | 0 | 0 | 12 | 0 | 0 |
| CP-NG | 37 | 0 | 0 | 4 | 0 | 0 |
| Total | 473 | 29 | 11 | 180 | 9 | 2 |